| Period Ending | Mar 30, 2013 | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 |
|---|
|
Total Revenue
|
74,457
|
89,698
|
89,825
|
83,052
| | Cost of Revenue | 39,618 | 45,789 | 45,778 | 40,197 | | |
Gross Profit
|
34,839
|
43,909
|
44,047
|
42,855
| |
|
Operating Expenses |
|
Research Development | 28,070 | 29,139 | 28,072 | 25,671 |
|
Selling General and Administrative | 12,538 | 12,209 | 12,684 | 15,559 |
|
Non Recurring |
-
| 897 |
-
|
-
|
|
Others | 930 | 930 | 930 | 715 |
|
|
|
Total Operating Expenses |
-
| 43,175 |
-
|
-
| | | |
Operating Income or Loss
|
(6,699)
|
734
|
2,361
|
910
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 428 | 34 | 31 | 246 |
|
Earnings Before Interest And Taxes | (7,051) | (11) | 1,593 | 251 |
|
Interest Expense |
-
|
-
|
-
|
-
|
|
Income Before Tax | (7,051) | (11) | 1,593 | 251 |
|
Income Tax Expense | (4,647) | (57) | 1,185 | 78 |
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | (3,184) | (733) | (391) | (732) | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
(2,404)
|
46
|
408
|
173
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
(2,404)
|
46
|
408
|
173
|
|
0.06(1.35%) 11:47AM EDT - Nasdaq Real Time Price